{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:12:25Z","timestamp":1790698345447,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jep.2022.115815","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T02:00:14Z","timestamp":1665194414000},"page":"115815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Piperlongumine overcomes imatinib resistance by inducing proteasome inhibition in chronic myelogenous leukemia cells"],"prefix":"10.1016","volume":"301","author":[{"given":"Xiaoying","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aochu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wa","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanjie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3668-4830","authenticated-orcid":false,"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2022.115815_bib1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0145-2126(01)00197-7","article-title":"Bcr-Abl variants: biological and clinical aspects","volume":"26","author":"Advani","year":"2002","journal-title":"Leuk. Res."},{"key":"10.1016\/j.jep.2022.115815_bib2","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1016\/j.febslet.2005.07.060","article-title":"Mechanism of direct degradation of IkappaBalpha by 20S proteasome","volume":"579","author":"Alvarez-Castelao","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jep.2022.115815_bib3","series-title":"Long pepper[M]\/\/Handbook of Herbs and Spices","first-page":"420","author":"Babu","year":"2006"},{"key":"10.1016\/j.jep.2022.115815_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejps.2012.12.003","article-title":"Overview of the therapeutic potential of piplartine (piperlongumine)","volume":"48","author":"Bezerra","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.jep.2022.115815_bib5","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.18632\/oncotarget.3444","article-title":"Piperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROS-ER-MAPKs-CHOP","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jep.2022.115815_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.biocel.2016.07.019","article-title":"The ubiquitin-proteasome system and autophagy: coordinated and independent activities","volume":"79","author":"Cohen-Kaplan","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jep.2022.115815_bib7","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/nm.2536","article-title":"Inhibition of proteasome deubiquitinating activity as a new cancer therapy","volume":"17","author":"D'Arcy","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jep.2022.115815_bib8","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.5958\/0974-360X.2019.00772.8","article-title":"In vitro anti-cancer study of vitis viniferae, ixora coccinea and piper longum extract on human prostate carcinoma cells","volume":"12","author":"Deeparani","year":"2019","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.jep.2022.115815_bib9","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1080\/10428190902895780","article-title":"Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells","volume":"50","author":"Dong","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jep.2022.115815_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2174\/1568009614666140804154511","article-title":"Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system","volume":"14","author":"Dou","year":"2014","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jep.2022.115815_bib11","doi-asserted-by":"crossref","first-page":"10793","DOI":"10.1007\/s13277-016-4792-9","article-title":"Piperlongumine induces gastric cancer cell apoptosis and G2\/M cell cycle arrest both in vitro and in vivo","volume":"37","author":"Duan","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jep.2022.115815_bib12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbrc.2013.06.012","article-title":"Piperlongumine inhibits LMP1\/MYC-dependent mouse B-lymphoma cells","volume":"436","author":"Han","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jep.2022.115815_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jep.2022.115815_bib14","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1038\/sj.emboj.7600832","article-title":"Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14","volume":"24","author":"Hu","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.jep.2022.115815_bib15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ajh.25011","article-title":"Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring","volume":"93","author":"Jabbour","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jep.2022.115815_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clml.2015.03.006","article-title":"Use of second- and third-generation tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: an evolving treatment paradigm","volume":"15","author":"Jabbour","year":"2015","journal-title":"Clin. Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.jep.2022.115815_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2013.01.017","article-title":"Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells","volume":"431","author":"Jarvius","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jep.2022.115815_bib18","doi-asserted-by":"crossref","first-page":"10317","DOI":"10.1021\/jm300434z","article-title":"Molecular mechanisms of acquired proteasome inhibitor resistance","volume":"55","author":"Kale","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jep.2022.115815_bib19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-145-12-200612190-00008","article-title":"New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance","volume":"145","author":"Kantarjian","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jep.2022.115815_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-016-0359-x","article-title":"Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr\/Abl-dependent and Bcr\/Abl-independent mechanisms","volume":"9","author":"Lan","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jep.2022.115815_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drup.2006.11.001","article-title":"The proteasome as a potential target for novel anticancer drugs and chemosensitizers","volume":"9","author":"Landis-Piwowar","year":"2006","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.jep.2022.115815_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0962-8924(98)01346-4","article-title":"Proteasome inhibitors: valuable new tools for cell biologists","volume":"8","author":"Lee","year":"1998","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jep.2022.115815_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120553","article-title":"Interaction analyses of hTAAR1 and mTAAR1 with antagonist EPPTB","volume":"300","author":"Liao","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.jep.2022.115815_bib24","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/cr.2016.86","article-title":"The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death","volume":"26","author":"Livneh","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.jep.2022.115815_bib25","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1111\/j.1742-4658.2011.08393.x","article-title":"Crystal structure of the catalytic domain of UCHL5, a proteasome-associated human deubiquitinating enzyme, reveals an unproductive form of the enzyme","volume":"278","author":"Maiti","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.jep.2022.115815_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113250","article-title":"Evaluation of the efficacy & biochemical mechanism of cell death induction by Piper longum extract selectively in in-vitro and in-vivo models of human cancer cells","volume":"9","author":"Ovadje","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2022.115815_bib27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.7624798","article-title":"Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27","volume":"269","author":"Pagano","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jep.2022.115815_bib28","doi-asserted-by":"crossref","first-page":"33542","DOI":"10.1074\/jbc.M113.511170","article-title":"Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells","volume":"288","author":"Pei","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jep.2022.115815_bib29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jep.2022.115815_bib30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1021\/jm301581y","article-title":"Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-Abelson (Bcr-Abl) kinase and overcomes clinically acquired mutation-induced resistance against imatinib","volume":"56","author":"Ren","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jep.2022.115815_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106156","article-title":"Targeting BCR-Abl in the treatment of Philadelphia-chromosome positive chronic myelogenous leukemia","volume":"178","author":"Roskoski","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jep.2022.115815_bib32","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1016\/j.bmcl.2014.10.054","article-title":"Synthesis and biological evaluation of piperlongumine derivatives as potent anti-inflammatory agents","volume":"24","author":"Seo","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jep.2022.115815_bib33","first-page":"358","article-title":"Cell cycle inhibitory activity of Piper longum against A549 cell line and its protective effect against metal-induced toxicity in rats","volume":"51","author":"Sharma","year":"2014","journal-title":"Indian J. Biochem. Biophys."},{"key":"10.1016\/j.jep.2022.115815_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1158\/1078-0432.CCR-13-1063","article-title":"Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation","volume":"20","author":"Shi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jep.2022.115815_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1248\/cpb.c18-00703","article-title":"Development of a potent protein degrader against oncogenic BCR-ABL protein","volume":"67","author":"Shibata","year":"2019","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.jep.2022.115815_bib36","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1038\/s41388-020-1253-0","article-title":"Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells","volume":"39","author":"Shibata","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jep.2022.115815_bib37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13287-016-0425-x","article-title":"Rapamycin regulates autophagy and cell adhesion in induced pluripotent stem cells","volume":"7","author":"Sotthibundhu","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jep.2022.115815_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/17512433.2018.1398644","article-title":"Pharmacology and pharmacokinetics of imatinib in pediatric patients","volume":"11","author":"Suttorp","year":"2018","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jep.2022.115815_bib39","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMc1007927","article-title":"Second-generation BCR-ABL kinase inhibitors in CML","volume":"363","author":"Tanimoto","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jep.2022.115815_bib40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2013-05-500033","article-title":"A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance","volume":"123","author":"Tian","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jep.2022.115815_bib41","first-page":"5345","article-title":"In vitro anti-cancer study of vitis viniferae, ixora coccinea and piper longum ethanolic extracts on human breast carcinoma cells","volume":"11","author":"Urolagin","year":"2018","journal-title":"Pharmaceut. Technol."},{"key":"10.1016\/j.jep.2022.115815_bib42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/978-981-15-0602-4_25","article-title":"Autophagy and ubiquitin-proteasome system","volume":"1206","author":"Wang","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jep.2022.115815_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112255","article-title":"A systematic review on Piper longum L.: bridging traditional knowledge and pharmacological evidence for future translational research","volume":"247","author":"Yadav","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2022.115815_bib44","doi-asserted-by":"crossref","first-page":"73497","DOI":"10.18632\/oncotarget.11988","article-title":"Piperlongumine induces apoptosis and reduces bortezomib resistance by inhibiting STAT3 in multiple myeloma cells","volume":"7","author":"Yao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jep.2022.115815_bib45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s13402-019-00471-x","article-title":"Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells","volume":"42","author":"Zhang","year":"2019","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.jep.2022.115815_bib46","article-title":"Piperlongumine inhibits lung tumor growth via inhibition of nuclear factor kappa B signaling pathway","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jep.2022.115815_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113471","article-title":"Overview of piperlongumine analogues and their therapeutic potential","volume":"220","author":"Zhu","year":"2021","journal-title":"Eur. J. Med. Chem."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874122008546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874122008546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:30:28Z","timestamp":1759944628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874122008546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":47,"alternative-id":["S0378874122008546"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2022.115815","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Piperlongumine overcomes imatinib resistance by inducing proteasome inhibition in chronic myelogenous leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2022.115815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115815"}}